<rss version="2.0" 
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
>

<channel>
	<title>News on Valeant Pharmaceuticals International from BioPortfolio.com</title>
	<link>http://www.BioPortfolio.com</link>
	<description>Consolidated Valeant Pharmaceuticals International news from BioPortfolio.com</description>
	<pubDate>Wed, 10 Feb 2010 09:58:59 GMT</pubDate>
	<language>en</language>
<atom:link href="http://www.bioportfolio.co.uk/cgi-bin/rssnews.pl?q=Valeant+Pharmaceuticals+International" rel="self" type="application/rss+xml" />

	
<item><title>Valeant Pharmaceuticals to Announce 2009 Fourth Quarter and Year Results on February 22, 2010</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4028998&amp;HITNO=0&amp;MSIZE=158&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valeant%20Pharmaceuticals%20International&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4028998&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2532947904%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4028998&amp;HITNO=0&amp;MSIZE=158&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valeant%20Pharmaceuticals%20International&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4028998&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2532947904%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Street Insider:</description></item>
<item><title>Valeant Pharmaceuticals to Announce 2009 Fourth Quarter and Year Results on February 22, 2010</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029870&amp;HITNO=1&amp;MSIZE=158&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valeant%20Pharmaceuticals%20International&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029870&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533316554%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029870&amp;HITNO=1&amp;MSIZE=158&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valeant%20Pharmaceuticals%20International&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029870&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533316554%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Pharma Live:</description></item>
<item><title>Valeant Pharmaceuticals to Announce 2009 Fourth Quarter and Year Results on February 22, 2010</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029390&amp;HITNO=2&amp;MSIZE=158&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valeant%20Pharmaceuticals%20International&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029390&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533120844%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029390&amp;HITNO=2&amp;MSIZE=158&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valeant%20Pharmaceuticals%20International&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029390&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533120844%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Wichita Business Journal:</description></item>
<item><title>Valeant Pharmaceuticals to Announce 2009 Fourth Quarter and Year Results on February 22, 2010</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029352&amp;HITNO=3&amp;MSIZE=158&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valeant%20Pharmaceuticals%20International&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029352&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533100931%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029352&amp;HITNO=3&amp;MSIZE=158&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valeant%20Pharmaceuticals%20International&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029352&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533100931%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Birmingham Business Journal:</description></item>
<item><title>Valeant Pharmaceuticals to Announce 2009 Fourth Quarter and Year Results on February 22, 2010</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029344&amp;HITNO=4&amp;MSIZE=158&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valeant%20Pharmaceuticals%20International&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029344&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533096667%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029344&amp;HITNO=4&amp;MSIZE=158&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valeant%20Pharmaceuticals%20International&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029344&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533096667%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>San Francisco Business Times:</description></item>
<item><title>Valeant Pharmaceuticals to Announce 2009 Fourth Quarter and Year Results on February 22, 2010</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029307&amp;HITNO=5&amp;MSIZE=158&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valeant%20Pharmaceuticals%20International&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029307&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533078108%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029307&amp;HITNO=5&amp;MSIZE=158&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valeant%20Pharmaceuticals%20International&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029307&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533078108%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Biz Journals:</description></item>
<item><title>Valeant Pharmaceuticals to Announce 2009 Fourth Quarter and Year Results on February 22, 2010</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029300&amp;HITNO=6&amp;MSIZE=158&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valeant%20Pharmaceuticals%20International&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029300&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533074551%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029300&amp;HITNO=6&amp;MSIZE=158&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valeant%20Pharmaceuticals%20International&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029300&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533074551%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Triangle Business Journal:</description></item>
<item><title>Valeant Pharmaceuticals to Announce 2009 Fourth Quarter and Year Results on February 22, 2010</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029241&amp;HITNO=7&amp;MSIZE=158&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valeant%20Pharmaceuticals%20International&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029241&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533050064%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029241&amp;HITNO=7&amp;MSIZE=158&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valeant%20Pharmaceuticals%20International&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029241&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533050064%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Sacramento Business Journal:</description></item>
<item><title>Valeant Pharmaceuticals to Announce 2009 Fourth Quarter and Year Results on February 22, 2010</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029239&amp;HITNO=8&amp;MSIZE=158&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valeant%20Pharmaceuticals%20International&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029239&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533046059%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029239&amp;HITNO=8&amp;MSIZE=158&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valeant%20Pharmaceuticals%20International&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029239&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533046059%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Boston Business Journal:</description></item>
<item><title>Valeant Pharmaceuticals to Announce 2009 Fourth Quarter and Year Results on February 22, 2010</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029198&amp;HITNO=9&amp;MSIZE=158&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valeant%20Pharmaceuticals%20International&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029198&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533028261%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029198&amp;HITNO=9&amp;MSIZE=158&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valeant%20Pharmaceuticals%20International&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029198&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533028261%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>San Jose Business Journal:</description></item>
<item><title>Valeant Pharmaceuticals to Announce 2009 Fourth Quarter and Year Results on February 22, 2010</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029177&amp;HITNO=10&amp;MSIZE=158&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valeant%20Pharmaceuticals%20International&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029177&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533022248%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029177&amp;HITNO=10&amp;MSIZE=158&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valeant%20Pharmaceuticals%20International&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029177&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533022248%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Charlotte Business Journal:</description></item>
<item><title>Valeant Pharmaceuticals to Announce 2009 Fourth Quarter and Year Results on February 22, 2010</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029176&amp;HITNO=11&amp;MSIZE=158&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valeant%20Pharmaceuticals%20International&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029176&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533021282%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029176&amp;HITNO=11&amp;MSIZE=158&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valeant%20Pharmaceuticals%20International&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029176&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533021282%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>San Jose Business Journal:</description></item>
<item><title>Valeant Pharmaceuticals to Announce 2009 Fourth Quarter and Year Results on February 22, 2010</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4028978&amp;HITNO=12&amp;MSIZE=158&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valeant%20Pharmaceuticals%20International&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4028978&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2532937587%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4028978&amp;HITNO=12&amp;MSIZE=158&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valeant%20Pharmaceuticals%20International&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4028978&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2532937587%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Individual.com:</description></item>
<item><title>Valeant Pharmaceuticals to Announce 2009 Fourth Quarter and Year Results on February 22, 2010</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029341&amp;HITNO=13&amp;MSIZE=158&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valeant%20Pharmaceuticals%20International&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029341&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533095711%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029341&amp;HITNO=13&amp;MSIZE=158&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valeant%20Pharmaceuticals%20International&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029341&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533095711%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Puget Sound Business Journal:</description></item>
<item><title>Valeant Pharmaceuticals to Announce 2009 Fourth Quarter and Year Results on February 22, 2010</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029278&amp;HITNO=14&amp;MSIZE=158&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valeant%20Pharmaceuticals%20International&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029278&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533064081%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029278&amp;HITNO=14&amp;MSIZE=158&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Valeant%20Pharmaceuticals%20International&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029278&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533064081%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>South Florida Business Journal:</description></item>
</channel></rss>